Loading...

Attendo

DB:7AT
Snowflake Description

Reasonable growth potential with adequate balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
7AT
DB
SEK10B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Attendo AB (publ) provides financed care and healthcare services in Sweden, Finland, Norway, and Denmark. The last earnings update was 8 days ago. More info.


Add to Portfolio Compare Print
  • Attendo has significant price volatility in the past 3 months.
7AT Share Price and Events
7 Day Returns
0.4%
DB:7AT
5.8%
DE Healthcare
2.2%
DE Market
1 Year Returns
-26.2%
DB:7AT
-20%
DE Healthcare
-11%
DE Market
7AT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Attendo (7AT) 0.4% -20.3% -23% -26.2% -22.4% -
DE Healthcare 5.8% 15.3% 2.5% -20% -13.1% 38.6%
DE Market 2.2% 2.7% 1.6% -11% 13.6% 6.8%
1 Year Return vs Industry and Market
  • 7AT underperformed the Healthcare industry which returned -20% over the past year.
  • 7AT underperformed the Market in Germany which returned -11% over the past year.
Price Volatility
7AT
Industry
5yr Volatility vs Market

Value

 Is Attendo undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Attendo to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data    Our calculation method for this is changing soon.

Below are the data sources, inputs and calculation used to determine the intrinsic value for Attendo.

DB:7AT Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 4 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:7AT
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 9.8%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.57
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.572 (1 + (1- 22%) (52.45%))
0.805
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.81
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.805 * 9.77%)
8.1%

Discounted Cash Flow Calculation for DB:7AT using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Attendo is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:7AT DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (SEK, Millions) 625.50 730.33 843.50 898.93 958.00
Source Analyst x2 Analyst x3 Analyst x2 Est @ 6.57% Est @ 6.57%
Present Value
Discounted (@ 8.1%)
578.64 624.99 667.76 658.32 649.01
Present value of next 5 years cash flows SEK3,178.71
DB:7AT DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= SEK958.00 × (1 + 0.23%) ÷ (8.1% – 0.23%)
SEK12,198.66
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= SEK12,198.66 ÷ (1 + 8.1%)5
SEK8,264.18
DB:7AT Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= SEK3,178.71 + SEK8,264.18
SEK11,442.89
Equity Value per Share
(SEK)
= Total value / Shares Outstanding
= SEK11,442.89 / 160.87
SEK6.51
DB:7AT Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:7AT represents 0.09148x of OM:ATT
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.09148x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (SEK) x Listing Adjustment Factor
= SEK 71.13 x 0.09148
€6.51
Value per share (EUR) From above. €6.51
Current discount Discount to share price of €5.80
= -1 x (€5.80 - €6.51) / €6.51
10.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Attendo is available for.
Intrinsic value
11%
Share price is €5.8 vs Future cash flow value of €6.51
Current Discount Checks
For Attendo to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Attendo's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Attendo's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Attendo's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Attendo's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:7AT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in SEK SEK2.00
OM:ATT Share Price ** OM (2019-02-22) in SEK SEK63.4
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 21.83x
Germany Market PE Ratio Median Figure of 420 Publicly-Listed Companies 18.09x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Attendo.

DB:7AT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OM:ATT Share Price ÷ EPS (both in SEK)

= 63.4 ÷ 2.00

31.69x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Attendo is overvalued based on earnings compared to the DE Healthcare industry average.
  • Attendo is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does Attendo's expected growth come at a high price?
Raw Data
DB:7AT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 31.69x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts
23.6%per year
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.29x
Germany Market PEG Ratio Median Figure of 277 Publicly-Listed Companies 1.38x

*Line of best fit is calculated by linear regression .

DB:7AT PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 31.69x ÷ 23.6%

1.34x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Attendo is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Attendo's assets?
Raw Data
DB:7AT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in SEK SEK38.61
OM:ATT Share Price * OM (2019-02-22) in SEK SEK63.4
Germany Healthcare Industry PB Ratio Median Figure of 12 Publicly-Listed Healthcare Companies 1.48x
Germany Market PB Ratio Median Figure of 565 Publicly-Listed Companies 1.8x
DB:7AT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OM:ATT Share Price ÷ Book Value per Share (both in SEK)

= 63.4 ÷ 38.61

1.64x

* Primary Listing of Attendo.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Attendo is overvalued based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess Attendo's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Attendo has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Attendo expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
23.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Attendo expected to grow at an attractive rate?
  • Attendo's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Attendo's earnings growth is expected to exceed the Germany market average.
  • Attendo's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:7AT Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:7AT Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 4 Analysts 23.6%
DB:7AT Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 4 Analysts 8.8%
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 2.6%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.4%
Germany Market Earnings Growth Rate Market Cap Weighted Average 9.9%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:7AT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
All numbers in SEK Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:7AT Future Estimates Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 16,464 1,416 1,092 1
2021-12-31 14,179 1,149 758 4
2020-12-31 13,130 1,028 656 4
2019-12-31 11,997 898 531 3
DB:7AT Past Financials Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income *
2018-12-31 10,987 935 321
2018-09-30 12,806 945 544
2018-06-30 12,224 853 558
2018-03-31 11,670 835 628
2017-12-31 11,157 899 680
2017-09-30 9,167 1,067 696
2017-06-30 9,515 1,055 697
2017-03-31 9,851 940 702
2016-12-31 10,212 914 649
2016-09-30 10,129 593 489
2016-06-30 10,016 699 447
2016-03-31 9,912 770 357

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Attendo's earnings are expected to grow significantly at over 20% yearly.
  • Attendo's revenue is expected to grow by 8.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:7AT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below

All data from Attendo Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:7AT Future Estimates Data
Date (Data in SEK Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 6.80 6.80 6.80 1.00
2021-12-31 4.72 5.84 4.04 4.00
2020-12-31 4.09 4.84 3.61 4.00
2019-12-31 3.29 3.40 3.10 3.00
DB:7AT Past Financials Data
Date (Data in SEK Millions) EPS *
2018-12-31 2.00
2018-09-30 3.39
2018-06-30 3.49
2018-03-31 3.93
2017-12-31 4.26
2017-09-30 4.36
2017-06-30 4.36
2017-03-31 4.39
2016-12-31 4.06
2016-09-30 3.06
2016-06-30 2.79
2016-03-31 2.23

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Attendo is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Attendo's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Attendo has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Attendo performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Attendo's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Attendo's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • Attendo's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Attendo's 1-year earnings growth is negative, it can't be compared to the DE Healthcare industry average.
Earnings and Revenue History
Attendo's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Attendo Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:7AT Past Revenue, Cash Flow and Net Income Data
Date (Data in SEK Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 10,987.00 321.00 2,818.00
2018-09-30 12,806.00 544.00 3,550.10
2018-06-30 12,224.00 558.00 3,338.10
2018-03-31 11,670.00 628.00 3,108.10
2017-12-31 11,157.00 680.00 2,917.10
2017-09-30 9,167.00 696.00 2,034.20
2017-06-30 9,515.00 697.00 2,190.20
2017-03-31 9,851.00 702.00 2,369.20
2016-12-31 10,212.00 649.00 2,558.20
2016-09-30 10,129.00 489.00 2,542.10
2016-06-30 10,016.00 447.00 2,436.10
2016-03-31 9,912.00 357.00 2,323.10
2015-12-31 9,831.00 286.00 2,239.10
2015-09-30 9,583.00 267.00 2,129.60
2014-12-31 9,045.00 263.00 1,897.60
2013-12-31 8,465.00 363.00 1,713.20
2012-12-31 7,891.00 159.00 1,472.50

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Attendo has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Attendo used its assets less efficiently than the DE Healthcare industry average last year based on Return on Assets.
  • Attendo's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Attendo's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Attendo has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Attendo's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Attendo's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Attendo is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Attendo's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Attendo's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Attendo Company Filings, last reported 1 month ago.

DB:7AT Past Debt and Equity Data
Date (Data in SEK Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 6,211.00 5,349.00 2,896.00
2018-09-30 5,691.00 5,368.00 519.00
2018-06-30 5,515.00 5,477.00 557.00
2018-03-31 5,623.00 5,434.00 718.00
2017-12-31 5,369.00 5,236.00 475.00
2017-09-30 5,113.00 3,562.00 304.00
2017-06-30 4,962.00 3,549.00 653.00
2017-03-31 5,002.00 3,343.00 689.00
2016-12-31 4,825.00 3,364.00 670.00
2016-09-30 4,718.00 3,504.00 508.00
2016-06-30 4,450.00 3,248.00 504.00
2016-03-31 4,357.00 3,401.00 708.00
2015-12-31 4,219.00 3,580.00 782.00
2015-09-30 2,772.00 5,111.00 977.00
2014-12-31 2,569.00 5,285.00 1,084.00
2013-12-31 2,308.00 5,054.00 856.00
2012-12-31 2,956.00 4,361.00 746.00
  • Attendo's level of debt (86.1%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (218.9% vs 86.1% today).
  • Debt is not well covered by operating cash flow (17.5%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 4.9x coverage).
X
Financial health checks
We assess Attendo's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Attendo has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Attendo's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.95%
Current annual income from Attendo dividends. Estimated to be 2.05% next year.
If you bought €2,000 of Attendo shares you are expected to receive €19 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Attendo's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1.52%).
  • Attendo's dividend is below the markets top 25% of dividend payers in Germany (3.91%).
Upcoming dividend payment

Purchase Attendo on or before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:7AT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 4 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.5%
Germany Market Average Dividend Yield Market Cap Weighted Average of 332 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:7AT Future Dividends Estimate Data
Date (Data in SEK) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 2.04 1.00
2021-12-31 1.43 4.00
2020-12-31 1.23 4.00
2019-12-31 0.98 3.00
DB:7AT Past Annualized Dividends Data
Date (Data in SEK) Dividend per share (annual) Avg. Yield (%)
2019-02-14 0.600 0.983
2018-04-12 1.270 1.586
2017-03-16 1.220 1.333
2017-02-15 1.220 1.396
2016-04-12 0.540 0.674

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Attendo has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Dividend payments have increased, but Attendo only paid a dividend in the past 3 years.
Current Payout to shareholders
What portion of Attendo's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3.3x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.6x coverage).
X
Income/ dividend checks
We assess Attendo's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Attendo afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Attendo has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Attendo's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Martin Tivéus
AGE 48
TENURE AS CEO 0.4 years
CEO Bio

Mr. Martin Folke Tivéus has been the Chief Executive Officer at Attendo AB (publ) since September, 2018 and has been its President since 2018. Mr. Tivéus is Director of Telia Company AB since March 2018. He served as Chief Commercial Officer Nordics at Klarna Bank AB (publ). Mr. Tivéus served as Chief Executive Officer of Evidensia Djursjukvård AB, Evidensia Djursjukvård Holding AB, Evidensia Acquisition AB and Evidensia Holding AB from 2016 to 2017. Mr. Tivéus served as Chief Executive Officer of Avanza Bank Holding AB / Avanza Bank AB from 2011 to 2016, General Manager of Microsoft Consumer & Online Business, Sweden from 2008 to 2011; Member of the Executive Management Team, Telenor Sweden Group from 2006 to 2008; Director of Marketing & Sales of Glocalnet AB from 2004 to 2006; Director of Marketing & Strategy, SAS Snowflake from 2003 to 2004; Deputy Managing Director and Head of Business Development, Head of Consulting CRM Practice, Digiscope Management Consulting from 1999 to 2003; and Manager of Member Communication and Program Development – SAS Eurobonus, Scandinavian Airlines AB from 1996 to 1999. He served as Marketing Director and Chief Executive Officer at Glocalnet AB from 2006 to 2008. He served as Chief Executive Officer of Attendo AB (publ). He has extensive executive management experience from large international companies. He has In-depth knowledge of digital banking, the consumer market, customer needs and change management. He was in SAS Management Trainee Program from 1995 to 1996. He was an Independent Director of Danske Bank A/S from March 16, 2017 until March 15, 2018. He serves as Director of Teracom Boxer Group AB. Mr. Tivéus received BSc in Business and Economics, University of Stockholm in 1995.

CEO Compensation
  • Insufficient data for Martin to compare compensation growth.
  • Insufficient data for Martin to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Attendo management team in years:

0.7
Average Tenure
44.5
Average Age
  • The average tenure for the Attendo management team is less than 2 years, this suggests a new team.
Management Team

Martin Tivéus

TITLE
CEO & President
AGE
48
TENURE
0.4 yrs

Fredrik Lagercrantz

TITLE
Chief Financial Officer
AGE
41
TENURE
0.9 yrs

Andreas Koch

TITLE
Communications & IR Director
AGE
41
TENURE
2.8 yrs

Pertti Karjalainen

TITLE
CEO of Attendo Finland
AGE
49
TENURE
0.1 yrs

Rebecca Birck

TITLE
Head of Corporate Control
Board of Directors Tenure

Average tenure and age of the Attendo board of directors in years:

2.8
Average Tenure
62
Average Age
  • The average tenure for the Attendo board of directors is less than 3 years, this suggests a new board.
Board of Directors

Ulf Lundahl

TITLE
Chairman of the Board
COMPENSATION
SEK925K
AGE
66
TENURE
1.8 yrs

Catarina Fagerholm

TITLE
Director
COMPENSATION
SEK475K
AGE
55
TENURE
2.8 yrs

Tobias Lönnevall

TITLE
Director
COMPENSATION
SEK650K
AGE
38
TENURE
2.8 yrs

Arja Pohjamäki

TITLE
Employee Representative Director
AGE
60
TENURE
12.1 yrs

Anssi Jyrki Soila

TITLE
Director
COMPENSATION
SEK400K
AGE
69
TENURE
12.1 yrs

Anitra Steen

TITLE
Director
COMPENSATION
SEK325K
AGE
69
TENURE
2.8 yrs

Alf Göransson

TITLE
Director
AGE
61
TENURE
0.8 yrs

Marco Donoso

TITLE
Alternate Representative Director
AGE
63
TENURE
2.1 yrs
Who owns this company?
Recent Insider Trading
  • Attendo insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
14. Feb 19 Buy Johan Spångö Individual 14. Feb 19 14. Feb 19 4,000 €5.70 €22,814
22. Nov 18 Sell Cecilia Addamshill Individual 20. Nov 18 20. Nov 18 -20,000 €7.67 €-153,450
22. Nov 18 Sell Ammy Wehlin Individual 20. Nov 18 20. Nov 18 -16,652 €7.70 €-128,142
26. Nov 18 Sell Cecilia Addamshill Individual 22. Nov 18 23. Nov 18 -100,000 €7.77 €-766,883
16. Nov 18 Sell Ammy Wehlin Individual 13. Nov 18 16. Nov 18 -96,849 €8.15 €-777,239
20. Nov 18 Sell Ammy Wehlin Individual 19. Nov 18 19. Nov 18 -29,776 €7.88 €-234,666
13. Nov 18 Sell Ammy Wehlin Individual 12. Nov 18 12. Nov 18 -50,000 €8.20 €-409,815
13. Sep 18 Buy Johan Spångö Individual 12. Sep 18 12. Sep 18 1,241 €8.33 €10,344
14. Sep 18 Buy Matias Pälve Individual 12. Sep 18 12. Sep 18 1,326 €8.33 €11,045
14. Sep 18 Buy Andreas Koch Individual 12. Sep 18 12. Sep 18 1,241 €8.33 €10,344
03. Sep 18 Buy Andreas Koch Individual 30. Aug 18 30. Aug 18 3,899 €7.84 €30,553
20. Aug 18 Sell Ammy Wehlin Individual 20. Aug 18 20. Aug 18 -98,997 €7.46 €-738,032
31. Jul 18 Sell Cecilia Addamshill Individual 30. Jul 18 30. Jul 18 -35,000 €7.59 €-265,708
13. Jun 18 Buy Matias Pälve Individual 12. Jun 18 12. Jun 18 1,438 €7.87 €11,320
14. Jun 18 Buy Johan Spångö Individual 12. Jun 18 12. Jun 18 1,352 €7.87 €10,640
14. Jun 18 Buy Andreas Koch Individual 12. Jun 18 12. Jun 18 1,352 €7.87 €10,640
30. Apr 18 Buy Andreas Koch Individual 26. Apr 18 26. Apr 18 76 €8.35 €634
01. May 18 Buy Johan Spångö Individual 26. Apr 18 26. Apr 18 86 €8.35 €716
29. Apr 18 Buy Matias Pälve Individual 26. Apr 18 26. Apr 18 38 €8.35 €315
29. Mar 18 Sell Ammy Wehlin Individual 29. Mar 18 29. Mar 18 -9,896 €7.73 €-76,458
28. Mar 18 Sell Ammy Wehlin Individual 26. Mar 18 26. Mar 18 -6,257 €7.83 €-49,012
22. Mar 18 Sell Cecilia Addamshill Individual 21. Mar 18 22. Mar 18 -30,000 €7.81 €-232,963
14. Mar 18 Buy Johan Spångö Individual 12. Mar 18 12. Mar 18 1,307 €8.13 €10,628
14. Mar 18 Buy Andreas Koch Individual 12. Mar 18 12. Mar 18 1,307 €8.13 €10,630
13. Mar 18 Buy Matias Pälve Individual 12. Mar 18 12. Mar 18 1,338 €8.13 €10,880
X
Management checks
We assess Attendo's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Attendo has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Map
Description

Attendo AB (publ) provides financed care and healthcare services in Sweden, Finland, Norway, and Denmark. The company offers care services for older people in nursing homes and home care. It also provides care services for people with disabilities; homes for children with special needs; consultant supported family home care services; crisis and acute accommodations; substance abuse care services; and care homes for people with neuropsychiatric conditions, as well as individuals and families. In addition, the company offers health care services, including primary, specialist, and dental, as well as medical care services; and medical personnel staffing services, such as general practitioners, specialist consultants, dentists, and nurses. It operates health centers; and acute and emergency care centers. The company was founded in 1985 and is headquartered in Danderyd, Sweden.

Details
Name: Attendo AB (publ)
7AT
Exchange: DB
Founded: 1985
SEK961,910,675
160,867,192
Website: http://www.attendo.com
Address: Attendo AB (publ)
Vendevägen 85,
Danderyd,
Stockholm County, 182 91,
Sweden
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OM ATT Class A Shares OMX Nordic Exchange Stockholm SE SEK 30. Nov 2015
DB 7AT Class A Shares Deutsche Boerse AG DE EUR 30. Nov 2015
LSE 0RCY Class A Shares London Stock Exchange GB SEK 30. Nov 2015
Number of employees
Current staff
Staff numbers
24,000
Attendo employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/22 22:38
End of day share price update: 2019/02/22 00:00
Last estimates confirmation: 2019/02/20
Last earnings filing: 2019/02/14
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.